# Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine

> **NCT04078698** · NA · COMPLETED · sponsor: **Fresenius Medical Care Deutschland GmbH** · enrollment: 34 (actual)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DEVICE:** Immunoadsorber GLOBAFFIN®

## Key facts

- **NCT ID:** NCT04078698
- **Lead sponsor:** Fresenius Medical Care Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-05
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-08-15
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078698, "Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04078698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*